Prosecution Insights
Prosecution Insights
25 pending office actions • 18 art units • 25 examiners • 0 of 25 (0%) have an AI response strategy ready • 29 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 10 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 10 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (8%) |
| §103 only | 10 (40%) |
| §112 only | 3 (12%) |
| Double-patenting + other | 1 (4%) |
| Multi-statute (no §101) | 9 (36%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GARCIA MIZE, KARLYANNIE MARIE | 1 | 36.2% | +29.1% |
| OJOFEITIMI, AYODEJI HARRY | 1 | 87.3% | +1.9% |
| CHONG, KIMBERLY | 1 | 72.4% | +12.8% |
| BOWERS, ERIN M | 1 | 55.1% | +10.5% |
| RYAN, DOUGLAS CHARLES | 1 | 40.3% | +50.7% |
| HA, NGUYEN Q | 1 | 80.2% | +4.3% |
| ARCORIA, PAUL JOSEPH | 1 | — | — |
| CHERNYSHEV, OLGA N | 1 | 54.5% | +34.2% |
| BOYLE, ROBERT C | 1 | 69.5% | -2.7% |
| HUMPHRIES, NICHOLAS ADAM | 1 | 33.3% | +78.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18042931 | METHODS TO PREVENT HIGH-GRADE SEROUS OVARIAN CANCER AND BREAST CANCER BY ADMINISTERING ANTIPROGESTINS | GAUGER, PAUL RANDALL | 37d overdue |
| 18262799 | PHARMACEUTICAL COMPOSITIONS AND THEIR METHODS OF USE | HUMPHRIES, NICHOLAS ADAM | 8d overdue |
| 18258673 | METHODS TO SENSITIZE CANCER CELLS AND STANDARDIZED SCREENING ASSAY FOR IMMUNOTHERAPY | BRAUN, MADELINE E | 8d overdue |
| 18040834 | IN VIVO LYMPHOVENOUS ANASTOMOSIS | SHIN, DANA H | 9d |
| 17913189 | IMMUNOTHERAPEUTIC TARGETS IN MULTIPLE MYELOMA AND METHODS FOR THEIR IDENTIFICATION | BUNKER, AMY M | 26d |
| 18541121 | POTENTIATING THE TUMOR-SELECTIVE EFFECTS OF NQO1-BIOACTIVATABLE AGENT BY USE OF CMET INHIBITOR | ARCORIA, PAUL JOSEPH | 28d |
| 18649689 | ANIMAL DRUG DELIVERY SYSTEM AND METHOD | OJOFEITIMI, AYODEJI HARRY | — |
| 18294722 | EPIGENETIC MODULATORS FOR TISSUE REPROGRAMMING | RYAN, DOUGLAS CHARLES | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18262799 | PHARMACEUTICAL COMPOSITIONS AND THEIR METHODS OF USE | HUMPHRIES, NICHOLAS ADAM | 8d overdue |
| 18811009 | TRANSPARENT, VERIFIABLE, MUTUALLY RESTRAINING ELECTRONIC VOTING | GARCIA MIZE, KARLYANNIE MARIE | — |
| 18694650 | DEPLETION OF FNDC5 REDUCES CANCER INDUCED MUSCLE LOSS/CACHEXIA | CHONG, KIMBERLY | — |
| 18599502 | TARGETS AND BIOMARKERS FOR TUMOR MICROENVIRONMENTS | BOWERS, ERIN M | — |
| 18294722 | EPIGENETIC MODULATORS FOR TISSUE REPROGRAMMING | RYAN, DOUGLAS CHARLES | — |
| 18546910 | METABOLIC BIOMARKERS FOR ASSESSING HEART FAILURE IN A SINGLE VENTRICLE PEDIATRIC SUBJECT | CHERNYSHEV, OLGA N | — |
| Art Unit | Apps |
|---|---|
| 1653 | 2 |
| 1621 | 2 |
| 1682 | 2 |
| 1635 | 2 |
| 3698 | 1 |
| 2853 | 1 |
| 1675 | 1 |
| 1764 | 1 |
| 1631 | 1 |
| 1799 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18811009 | TRANSPARENT, VERIFIABLE, MUTUALLY RESTRAINING ELECTRONIC VOTING | GARCIA MIZE, KARLYANNIE MARIE | 3698 | §103 | Non-Final OA | — | Pending | Aug 21, 2024 |
| 18649689 | ANIMAL DRUG DELIVERY SYSTEM AND METHOD | OJOFEITIMI, AYODEJI HARRY | — | §103§112 | Non-Final OA | — | Pending | Apr 29, 2024 |
| 18694650 | DEPLETION OF FNDC5 REDUCES CANCER INDUCED MUSCLE LOSS/CACHEXIA | CHONG, KIMBERLY | — | §112 | Non-Final OA | — | Pending | Mar 22, 2024 |
| 18599502 | TARGETS AND BIOMARKERS FOR TUMOR MICROENVIRONMENTS | BOWERS, ERIN M | 1653 | §102§103DP | Non-Final OA | — | Pending | Mar 08, 2024 |
| 18294722 | EPIGENETIC MODULATORS FOR TISSUE REPROGRAMMING | RYAN, DOUGLAS CHARLES | — | §102§103§112 | Non-Final OA | — | Pending | Feb 02, 2024 |
| 18294443 | METHODS OF TREATING COMPROMISED LUNG FUNCTION AND ASSESSING CLINICAL IMPROVEMENT | HA, NGUYEN Q | 2853 | §101§103 | Final Rejection | — | Pending | Feb 01, 2024 |
| 18541121 | POTENTIATING THE TUMOR-SELECTIVE EFFECTS OF NQO1-BIOACTIVATABLE AGENT BY USE OF CMET INHIBITOR | ARCORIA, PAUL JOSEPH | 1621 | §102§103§112 | Non-Final OA | 28d | Pending | Dec 15, 2023 |
| 18546910 | METABOLIC BIOMARKERS FOR ASSESSING HEART FAILURE IN A SINGLE VENTRICLE PEDIATRIC SUBJECT | CHERNYSHEV, OLGA N | 1675 | §112 | Non-Final OA | — | Pending | Aug 17, 2023 |
| 18264508 | SYNTHESIS OF PEG-BASED THIOL-NORBORNENE HYDROGELS WITH TUNABLE HYDROYLITIC DEGRADATION PROPERTIES | BOYLE, ROBERT C | 1764 | §102§103§112 | Non-Final OA | — | Pending | Aug 07, 2023 |
| 18262799 | PHARMACEUTICAL COMPOSITIONS AND THEIR METHODS OF USE | HUMPHRIES, NICHOLAS ADAM | 1631 | §102§103 | Final Rejection | 8d overdue | Pending | Jul 25, 2023 |
| 18272455 | A DEVICE HAVING A SUPPORT STRUCTURE FOR CREATING A HOLLOW, THREE-DIMENSIONAL ORGANOIDS AND CULTURES | LOPEZLIRA, ASHLEY NICOLE | 1799 | §103 | Final Rejection | — | Pending | Jul 14, 2023 |
| 18261451 | METHODS TO PREDICT EFFECTS OF PERIOPERATIVE ADMINISTRATION OF METHADONE TO OPTIMIZE PAIN RELIEF AND AVOID ADVERSE EFFECTS | GOLDBERG, JEANINE ANNE | 1682 | §103 | Non-Final OA | — | Pending | Jul 13, 2023 |
| 18260115 | TOCOTRIENOL COMPOSITIONS AND METHODS TO TREAT NON-ALCOHOLIC STEATOHEPATITIS | KOSTURKO, GEORGE W | 1621 | §103 | Final Rejection | 14d | Pending | Jun 30, 2023 |
| 18258673 | METHODS TO SENSITIZE CANCER CELLS AND STANDARDIZED SCREENING ASSAY FOR IMMUNOTHERAPY | BRAUN, MADELINE E | 1624 | §103§112 | Final Rejection | 8d overdue | Pending | Jun 21, 2023 |
| 18027476 | FOXP3S-PROMOTING MORPHOLINOS | MEYERING, SHABANA SHABBEER | 1635 | §103 | Final Rejection | 5d overdue | Pending | Mar 21, 2023 |
| 18024488 | METHODS FOR EARLY DETECTION OF BREAST CANCER | TURPIN, ZACHARY MARK | 1682 | §103§112 | Final Rejection | — | Pending | Mar 02, 2023 |
| 18042931 | METHODS TO PREVENT HIGH-GRADE SEROUS OVARIAN CANCER AND BREAST CANCER BY ADMINISTERING ANTIPROGESTINS | GAUGER, PAUL RANDALL | 1629 | §102§103 | Final Rejection | 37d overdue | Pending | Feb 24, 2023 |
| 18040834 | IN VIVO LYMPHOVENOUS ANASTOMOSIS | SHIN, DANA H | 1635 | §103§112 | Final Rejection | 9d | Pending | Feb 07, 2023 |
| 18009805 | COMPOSITIONS AND METHODS FOR REPROGRAMMING SKIN TISSUE TO HAVE INSULINOGENIC AND DELIVERY FUNCTIONS | NICOL, ALEXANDER W | 1634 | §103 | Final Rejection | — | Pending | Dec 12, 2022 |
| 17923055 | COMPOSITIONS AND METHODS FOR PROMOTING PROLIFERATION IN CARDIOMYOCYTES | STAVROU, CONSTANTINA E | 1632 | §112 | Final Rejection | — | Pending | Nov 03, 2022 |
| 17966286 | MAPPING CRITICAL BRAIN SITES USING INTRACRANIAL ELECTROPHYSIOLOGY AND MACHINE LEARNING | JASANI, ASHISH SHIRISH | 3798 | §103 | Non-Final OA | — | Pending | Oct 14, 2022 |
| 17937136 | SEI PREFORMED GRAPHITE AND ASSOCIATED METHODS, APPARATUS, AND PRODUCTS | JACOBSON, SARAH JORDAN | 1785 | §103 | Non-Final OA | — | Pending | Sep 30, 2022 |
| 17913189 | IMMUNOTHERAPEUTIC TARGETS IN MULTIPLE MYELOMA AND METHODS FOR THEIR IDENTIFICATION | BUNKER, AMY M | 1684 | §101§102§112 | Non-Final OA | 26d | Pending | Sep 21, 2022 |
| 17870785 | N-PROPANOL/H2O MIXED SOLVENT COMPOSITIONS FOR MEMBRANE ELECTRODE ASSEMBLIES | LYNCH, VICTORIA HOM | 1724 | §103 | Final Rejection | 163d overdue | Pending | Jul 21, 2022 |
| 17761121 | PROLONGED FUNCTION OF LIVER ORGANOIDS BY 3D COCULTURING OF HEPATIC LINAGE CELLS AS AN IN VITRO MODEL FOR THE STUDY OF LIVER DISEASE | BARRON, SEAN C | 1653 | §103 | Final Rejection | 30d overdue | Pending | Mar 16, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial